Spatz3 News
Spatz3 is the world’s only Adjustable Gastric Balloon System
Commercial Launch USA
Spatz Medical, a global leader in gastrointestinal weight loss solutions, is delighted to announce the commencement of commercialization of the Spatz3 Adjustable Gastric Balloon. With over 150,000 patients benefiting from the Spatz3 across more than sixty markets globally, the company is now poised to launch this revolutionary technology in the United States.
02/29/2024
Yahoo Finance / The Lancet
Spatz is proud to announce that the Spatz3 Adjustable Balloon FDA pivotal trial results were published in The Lancet
31/01/22
Spatz Medical FDA
Following FDA approval of the Spatz3 Adjustable balloon in October 2021, enrollment of Spatz3 patients in the FDA post approval study had begun. This study is routine for all intra-gastric balloon companies that receive FDA approval and is somewhat equivalent to a registry so that FDA can monitor Spatz patients as they are treated in many clinical sites across the United States. More than 20 clinical sites were very eager to use the Spatz3 balloon. Once all patients are enrolled in the study, full commercialization of the Spatz Balloon will commence in the United States.
01/12/21
FDA Approval Press Release
Spatz3 is the fifth balloon to receive FDA approval and its pivotal FDA clinical trial results demonstrated a 15% decrease in weight and an 84% success rate.
23/10/21
FDA Results
Results from Spatz Medical FDA clinical trials confirm that Spatz3, the only Adjustable Gastric Balloon, delivers the highest success rates of all gastric balloons.
20/05/19
DDW 2022
DDW resumes in 2022 after 2 years of being strictly “virtual”, this year’s meeting is back in San Diego CA. Spatz will be exhibiting for 3 days beginning May 22nd. Our staff will be happy to meet you and ready to answer all your questions at booth #2310 at the San Diego Convention Center, located at 111 W Harbor Dr, San Diego, CA 92101, United States.
21/05/22
Obesity Week Las Vegas
The Obesity Society’s Annual Meeting at ObesityWeek is one of the world’s largest gatherings of obesity professionals in all stages of their careers. The conference is your opportunity to learn from the leading players in the field of obesity from world-renowned researchers, physicians, surgeons, policymakers and more. The full ObesityWeek conference (scientific sessions) plus the pre-conference review course offers up to 30.00 AMA PRA Category 1 Credits™.
07/11/19
DDW 2019
Recognized as one of the top 50 medical meetings by HCEA, Digestive Disease Week® (DDW) is the world’s largest gathering of physicians, researchers and industry in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery.
21/05/19
Obesity Week Nashville
The Obesity Society’s Annual Meeting at ObesityWeek is one of the world’s largest gatherings of obesity professionals in all stages of their careers. The conference is your opportunity to learn from the leading players in the field of obesity from world-renowned researchers, physicians, surgeons, policymakers and more. The full ObesityWeek conference (scientific sessions) plus the pre-conference review course offers up to 30.00 AMA PRA Category 1 Credits™.
15/11/18
DDW 2018
Digestive Disease Week® (DDW) will host its annual scientific meeting in Washington, D.C., from June 2-5, 2018, bringing together physicians, researchers, and academics from across the world. Recognized as a top 50 medical meeting, this is your opportunity to learn cutting-edge medical advances and report on the latest research in gastroenterology, hepatology, endoscopy and gastrointestinal surgery.
15/06/18
ObesityHelp Overview
Discover Dr. Cynthia Weber’s review in ObesityHelp about the advantages of the Spatz3 and outlines a little more about the procedure in the United States.
25/08/22
Receive your free 4 -step guide today!
In each step, you’ll learn new tips to help you choose the RIGHT weight loss solution!